Lipocine

Lipocine

Yahoo Finance • 4 days ago

Lipocine (LPCN) Upgraded to Buy: What Does It Mean for the Stock?

Lipocine (LPCN) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock p... Full story

Yahoo Finance • 2 months ago

Lipocine Appoints Michael J. Grissinger to Board of Directors

SALT LAKE CITY, Aug. 3, 2026 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics through effective oral delivery, today announced the appointment... Full story

Yahoo Finance • last year

Lipocine stock maintains Buy rating at H.C. Wainwright amid Phase 3 progress

Investing.com - H.C. Wainwright has reiterated its Buy rating and $8.00 price target on Lipocine Inc (NASDAQ:LPCN) following the company’s second-quarter financial results and clinical progress. The stock, currently trading at $3.04, appea... Full story

Yahoo Finance • last year

Lipocine stock maintains Buy rating at H.C. Wainwright on PPD treatment potential

Investing.com - H.C. Wainwright has reiterated a Buy rating and $8.00 price target on Lipocine Inc (NASDAQ:LPCN) following the company’s recent R&D event focused on postpartum depression (PPD (NASDAQ:PPD)) treatment. The research firm hig... Full story